Nephros Inc (NEPH):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Nephros Inc (NEPH) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6435
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nephros Inc (Nephros) is dialysis device manufacturer. The company offers infection control filters, dialysis ultrafilters, and hemodia filtration systems. Its dialysis ultrafilters includes Endotoxin ten Cartridge filter, SSUmini, DSU-D and SSU-D. Nephros dialysis ultrafilters are intended to be used to filter water and bicarbonate concentrate used in hemodialysis devices to assist in providing hemodialysis quality water or bicarbonate concentrates. The company offers infection control filters such as ice machine solutions, shower solutions and sink products. Its products are used in conjunction with other water treatment equipment. Nephros dialysis products are used in removal of biological contaminants. The company markets its products through a network of distributors in the US. Nephros is headquartered in South Orange, New Jersey, the US.

Nephros Inc (NEPH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Nephros Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Nephros Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Nephros Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Nephros Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Nephros Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Nephros Inc, Medical Equipment, Deal Details 11
Partnerships 11
Nephros Extends Licensing Agreement With Bellco For Mid-Dilution Dialysis Products 11
Nephros Enters into Agreement with CS Medical 12
Nephros And Mar Cor Purification Enter Into Distribution Agreement For Dialysis Ultrafilters 13
Equity Offering 14
Nephros Raises USD2.9 Million in Private Placement of Shares 14
Nephros Raises USD1.2 Million in Private Placement of Shares and Warrants 15
Nephros Raises USD0.2 Million in Private Placement of Shares upon Exercise of Warrants 16
Nephros to Raise USD10 Million in Private Placement of Shares 18
Nephros Raises USD1.2 Million in Private Placement of Shares 20
Nephros Raises USD3 Million in Rights Offering 21
Nephros Completes Rights Offering Of Shares For US$2 Million 22
Nephros Completes Rights Offering Of Shares For US$3 Million 23
Nephros Inc – Key Competitors 24
Nephros Inc – Key Employees 25
Nephros Inc – Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Financial Announcements 27
Aug 08, 2018: Nephros reports second quarter 2018 financial results 27
Jul 09, 2018: Nephros Announces Preliminary Financial Results for Second Quarter 2018 28
May 09, 2018: Nephros Reports First Quarter 2018 Financial Results 29
Apr 16, 2018: Nephros Announces Preliminary Financial Results For First Quarter 2018 30
Feb 26, 2018: Nephros Reports 2017 Fourth Quarter and Full Year Financial Results and Provides Corporate Update 31
Jan 04, 2018: Nephros Announces Preliminary Financial Results for Fourth Quarter 2017 33
Nov 09, 2017: Nephros Reports Third Quarter 2017 Financial Results 34
Aug 08, 2017: Nephros Reports Second Quarter Financial Results and Receives NJEDA Approval for Approximately $1.5 million in Funding from Sale of Tax Credits 35
May 09, 2017: Nephros Reports 2017 First Quarter Financial Results and Provides Corporate Update 36
Mar 20, 2017: Nephros Reports 2016 Fourth Quarter and Full Year Financial Results and Provides Corporate Update 37
Jan 24, 2017: Nephros Provides Corporate Update and Fourth Quarter 2016 Revenue Guidance 39
Corporate Communications 41
Aug 13, 2018: Nephros appoints Oliver Spandow to its board of directors 41
Nov 06, 2017: Nephros Announces Approval of $1.9 Million in NJEDA NOL Program Tax Credits 42
Feb 14, 2017: Nephros Announces Appointment of Andrew Astor as Chief Financial Officer 43
Product News 44
Dec 04, 2017: Nephros CFO to Present at the 10th Annual LD Micro Main Event 44
Other Significant Developments 45
Oct 16, 2017: Nephros Provides Corporate Update and Announces Preliminary Third Quarter 2017 Revenue 45
Sep 27, 2017: Nephros Shareholder Letter 46
Jul 10, 2017: Nephros Provides Corporate Update and Second Quarter 2017 Revenue Guidance 48
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Tables
Nephros Inc, Medical Equipment, Key Facts, 2017 2
Nephros Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Nephros Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Nephros Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Nephros Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Nephros Inc, Deals By Market, 2012 to YTD 2018 9
Nephros Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Nephros Extends Licensing Agreement With Bellco For Mid-Dilution Dialysis Products 11
Nephros Enters into Agreement with CS Medical 12
Nephros And Mar Cor Purification Enter Into Distribution Agreement For Dialysis Ultrafilters 13
Nephros Raises USD2.9 Million in Private Placement of Shares 14
Nephros Raises USD1.2 Million in Private Placement of Shares and Warrants 15
Nephros Raises USD0.2 Million in Private Placement of Shares upon Exercise of Warrants 16
Nephros to Raise USD10 Million in Private Placement of Shares 18
Nephros Raises USD1.2 Million in Private Placement of Shares 20
Nephros Raises USD3 Million in Rights Offering 21
Nephros Completes Rights Offering Of Shares For US$2 Million 22
Nephros Completes Rights Offering Of Shares For US$3 Million 23
Nephros Inc, Key Competitors 24
Nephros Inc, Key Employees 25

List of Figures
Nephros Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Nephros Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Nephros Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Nephros Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Nephros Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Nephros Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Nephros Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Nephros Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Nephros Inc (NEPH):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Second Cup Ltd.:企業の戦略・SWOT・財務分析
    The Second Cup Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Second Cup Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • RTI Surgical Inc (RTIX):企業の財務・戦略的SWOT分析
    Summary RTI Surgical Inc (RTI), formerly RTI Biologics Inc is a surgical implant company that offers biologic, metal and synthetic implants. The company’s products include spine implants, surgical specialties, sports medicine implants, cardiothoracic and orthobiologics. It offers spine implants such …
  • ELMOS Semiconductor AG (ELG):企業の財務・戦略的SWOT分析
    ELMOS Semiconductor AG (ELG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Haier Electronics Group Co Ltd:企業の戦略・SWOT・財務情報
    Haier Electronics Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Haier Electronics Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Avadel Pharmaceuticals Plc (AVDL):医療機器:M&Aディール及び事業提携情報
    Summary Avadel Pharmaceuticals Plc (Avadel), formerly Flamel Technologies SA is a specialty pharmaceutical company, which develops and commercializes drugs for allergy, asthma, central nervous system (CNS) (narcolepsy), pain, respiratory diseases and diabetes. The company’s products are built on its …
  • PT Bayan Resources Tbk.:企業の戦略・SWOT・財務情報
    PT Bayan Resources Tbk. - Strategy, SWOT and Corporate Finance Report Summary PT Bayan Resources Tbk. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Philippine Long Distance Telephone Company:企業のM&A・事業提携・投資動向
    Philippine Long Distance Telephone Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Philippine Long Distance Telephone Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …
  • LeasePlan Corporation N.V.:企業の戦略・SWOT・財務情報
    LeasePlan Corporation N.V. - Strategy, SWOT and Corporate Finance Report Summary LeasePlan Corporation N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • PT. Bank Rakyat Indonesia (Persero) Tbk.:戦略・SWOT・企業財務分析
    PT. Bank Rakyat Indonesia (Persero) Tbk. - Strategy, SWOT and Corporate Finance Report Summary PT. Bank Rakyat Indonesia (Persero) Tbk. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Lutron Electronics Co Inc:企業の戦略的SWOT分析
    Lutron Electronics Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Zogenix Inc (ZGNX):企業の財務・戦略的SWOT分析
    Zogenix Inc (ZGNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • R. R. Donnelley & Sons Co (RRD):企業の財務・戦略的SWOT分析
    R. R. Donnelley & Sons Co (RRD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Viavi Solutions Inc
    Viavi Solutions Inc - Strategy, SWOT and Corporate Finance Report Summary Viavi Solutions Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • First Derivatives plc (FDP):企業の財務・戦略的SWOT分析
    First Derivatives plc (FDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Meritor, Inc.:企業の戦略・SWOT・財務分析
    Meritor, Inc. - Strategy, SWOT and Corporate Finance Report Summary Meritor, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Botswana Power Corporation:企業の戦略的SWOT分析
    Botswana Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Strukton Groep NV:企業の戦略・SWOT・財務情報
    Strukton Groep NV - Strategy, SWOT and Corporate Finance Report Summary Strukton Groep NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Pfizer Inc (PFE):企業の財務・戦略的SWOT分析
    Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Tokyo Electric Power Company Holdings Inc (9501):企業の財務・戦略的SWOT分析
    Tokyo Electric Power Company Holdings Inc (9501) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Culture Landmark Investment Ltd:企業の戦略・SWOT・財務分析
    Culture Landmark Investment Ltd - Strategy, SWOT and Corporate Finance Report Summary Culture Landmark Investment Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆